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Abstract 
Purpose: To assess the impact of pharmacist-led multifactorial interventions on health parameters, 
medication adherence, and disease-related knowledge among type 2 diabetic patients in southern Punjab, 
Pakistan. 
Methods: The effect of intervention was evaluated by randomly assigning patients into control group (n = 
170), receiving conventional medical care, and intervention group (n = 178), receiving predefined 
specialized care. The primary outcome of this intervention study was improvement in glycemic control which 
was assessed by measuring fasting blood glucose and glycosylated haemoglobin (HbA1c) values. 
Results: The outcomes obtained clearly show the role of pharmacist counseling in the control of type 2 
diabetes while improving fasting blood glucose (FBG) and HbA1c levels, reduction in Body Mass Index 
(BMI), improvement in disease knowledge as well as reduction in smoking. The intervention significantly 
reduced BMI and waist circumference by a difference of 1.87 (p = 0.014) and 1.27 (p = 0.002) between 
control and intervention groups. Glycemic control was significant within the intervention group, as evident by 
a reduction in fasting blood glucose level {-19.26 mg/dL (p = 0.003)} and HbA1c level {-1.01 % (p < 0.001)} 
compared to control group. The mean difference in glycemic control between both groups was insignificant 
but mild reductions were seen in fasting blood glucose (-11.95 mg/dL, p = 0.11) and HbA1c (-0.43 %, p = 
0.12). A significant increase in disease-related knowledge was seen in the intervention group, compared to 
the control group which was evident by mean differences in compliance (p = 0.003), foot-care (p < 0.001) 
and self-monitoring of blood glucose (p = 0.001).  
Conclusion: The purpose of study was achieved in that it demonstrates that pharmacists can play a pivotal 
role in improving glycemic control in diabetic patients and that involvement of pharmacists in diabetic clinics 
is beneficial to the patients in terms of medication adherence and promotion of healthy lifestyle.  
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The worldwide rising prevalence of diabetes can 
be directly related to economic development, 
ageing population, increasing population, dietary 
changes, and decrease in physical activity [1].  It 
is predicted that in 2030, the number of diabetes 
patients worldwide will rise to 472 million and 
80% of them will be residents of low and middle-
income countries [2]. 
 
Medication adherence may be defined as “the 
extent to which a person’s behavior coincides 
with medical advice” [3]. The rate of non-
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adherence to long-term therapies for chronic 
illnesses in developed countries is about 50% 
and these rates are much lower in developing 
countries. Adherence to medications among 
diabetes patients is very poor, and it varies 
widely in different geographical areas  with 
adherence rates between 36 and 94 % [4,5]. 
It has been shown that pharmacists’ intervention 
can improve clinical outcomes by improving 
medications use in outpatients [6]. The 
complications associated with diabetes can be 
reduced with the help of disease specific 
interventions for achieving glycemic control. Data 
suggest that a large proportion of patients with 
diabetes have high HbA1c values [7]. The effect 
of the pharmacist’s intervention in diabetes has 
proven to be effective in lowering fasting blood 
glucose and HbA1c values. Improvement in self-
management and better knowledge of diabetes 
was seen with pharmacist led diabetes education 
program [8]. 
 
The overall objective of this study was to assess 
the impact of pharmacist-led interventions  on 
glycemic control, medication adherence, disease 
knowledge, and lifestyle modifications among 







The method used for this study was based on 
questionnaire designed to collect information 
such as gender, age, BMI, waist circumference, 
smoking history, education, diabetes type, blood 
pressure (BP), oral hypoglycemic agents used, 
insulin use, HbA1c level and FBG to access 
patient condition and awareness of disease-
related knowledge.  
 
This study design was interventional and carried 
out for a 5-month period in selected diabetes 
clinics in southern Punjab (Nishter Hospital 
Multan and DHQ Hospital Layyah). The study 
was performed in accordance with the 
international clinical guidelines and prior written 
permissions were taken from the patients. The 




Diabetic patients who were receiving an oral 
hypoglycemic medication from at least last 6 
months and were having BMI more than 25 were 
included in this study. Patients solely on insulin 
therapy were not included in the study due to 
lack of knowledge regarding proper insulin 
administration method and dose calculation. 
Patient groups and intervention 
 
Patients were randomly assigned into control 
(n=170) and intervention groups (n=178). 
Patients in the control group received usual 
medical care. Patients in the intervention group 
received pre-defined specialized care during the 
whole study. Five pharmacists were the part of 
the study team, and all of them had a 
background in clinical pharmacy and a minimum 
experience of 3 years in hospital setting. The 
components of the pre-defined care were:  
 
I. Education of disease including short and 
long term complications 
II. Medication adherence and its effects on 
glycemic control 
III. Education regarding timing of medication 
use in relation to food 
IV. Education regarding dietary restrictions 
V. Education regarding sensory changes 
including foot examination 
VI. Role of exercise in achieving glycemic 
control 
VII. Role of self-monitoring of blood glucose  
in achieving glycemic control 
VIII. Education regarding control of Hb1c 
values  and fasting blood glucose in 
diabetes patients 
IX. Smoking cessation 
 
Outcomes measures  
  
Patients included in both control and intervention 
groups were asked to perform fasting blood 
sugar tests every 4 weeks at 0,4,8,12,16 and 20 
weeks. Patients were asked to test their HbA1c 
values at the start and at the end of the study. 
Self-reporting approach was used to assess 
adherence to medications. Knowledge regarding 
disease, self-monitoring, and lifestyle 
modifications were assessed on yes/no basis at 




Sample size was determined by a standard 
statistical formula [9] and was found to be 163 in 
each group. Statistical analysis was performed 
using statistical software SPSS version 16.0 
(SPSS Inc, Chicago, Ill). A two tailed significance 
level of 0.05 was used in the study. Independent 
t-tests and Chi-Square tests were used for. 
comparing baseline data with group values. 
Results of the continuous variables between 
control and intervention groups were analyzed 
using paired sample t-tests. Independent sample 
t-tests were used to evaluate mean differences 
between control and intervention groups from 
baseline. Evaluation of non-parametric 
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responses was done by using Wilcoxon signed 
ranks test for assessment of differences within 
each group between time 0 and 20 weeks. 
Mann-Whitney U-test was used to evaluate mean 
differences in responses between control and 




Patients visiting various diabetic clinics in 
Southern Punjab during the period of  March, 
2011 to May, 2011 meeting the inclusion criteria 
were selected and assigned randomly into  
control (n=170) and intervention group (n=178). 
Almost all the patients included completed the 
study (control group: 168/170 and intervention 
group: 174/178). Reasons for dropout were 
mainly non-affordability of medication and 
traveling costs to keep hospital appointments. 
Lack of motivation and one patient died during 
follow-up. The baseline characteristics of both 
study groups were similar and are shown in 
Table 1. Baseline HbA1c values were available 
for 97 control group and 108 intervention group 
patients. 
 
BMI and waist circumference  
 
Significant reductions from baseline in BMI and 
waist circumference were seen in the 
intervention group {BMI (-2.46, P=0.002), waist 
circumference (-2.24 inches, P<0.001)}, Table 2.  
The reductions were not significant in control 
group (-0.59, P=0.08) but BMI reductions were 
insignificant (-0.97 inches, P=0.46). Mean 
differences of BMI and waist circumference 
between control and intervention group were 




There was significant reduction in fasting blood 
glucose and HbA1c values in the intervention 
group (-19.26 mg/dL, p = 0.003 and -1.01 %, p < 
0.001). Reductions were seen in fasting blood 
glucose and HbA1c values (-7.31 mg/dL and -
0.46 %) in control group but were insignificant (p 
= 0.23 and 0.11). Mean differences of fasting 
blood glucose and HbA1c values between 
control and intervention group from baseline 
were not significant (p = 0.116 and 0.112).  
 
 
Adherence to medications 
 
Adherence to medication was assessed by self-
report of the patients in both groups. 
Improvements in adherence rates were seen in 
both control and intervention groups. These 
improvements were significant in intervention 
group as compared to control group (p = 0.052 
vs 0.310). Differences between control and 
intervention groups from baseline were 
significant (p = 0.003). 
 
Disease knowledge and self-care activities 
 
There was significant improvement in patient’s 
disease knowledge and self-care activities in the 
intervention group as shown in Table 3. 
Intervention group showed improvement 
regarding knowledge of sensory changes (p = 
0.001), foot care (p = 0.012), self-monitoring of 
blood sugar (p = 0.002), role of exercise (p = 
0.011) and dietary restrictions (p = 0.001). Mean 
differences between control and intervention 
groups from baseline were significant in 
knowledge regarding sensory changes (p < 
0.001), self-monitoring of blood sugar and role of 
exercise (p < 0.001). 
 
Smoking cessation  
 
There was an increase in the percentage of non-
smokers in both groups. The increase in non-
smokers was significant in intervention group (p 
= 0.019) but was insignificant in control group (p 
= 0.564). The difference between control and 
intervention group on smoking rates was not 
significant (p = 0.491). 
 
Baseline characteristics of study groups  
 
With  regard to care in type 2 diabetic patients, it 
was observed that pharmacist interaction in 
these patients led to control of blood glucose 
level. The beneficial role of pharmacist 
intervention was even more evident with regard 
to BMI, waist circumference and HbA1c than for 
FBG. Similarly, patient compliance significantly 
increased with pharmacist counseling on a 
regular basis. This was seen in patients in the 





It was found that multifactorial interventions in 
diabetic patients resulted in improvement in 
glycemic control which was evident from 
significant reductions in fasting blood glucose 
level and HbA1c values. The role of the 
pharmacist in the management of diabetes has 
been established and various studies have been 
done to prove the effects of pharmacists’ 
intervention on glycemic control [10]. 
Pharmacist’s involvement in the management of 
diabetic patients with the physician has led to 
improved glycemic control and lipid levels [11]. It 
is   the  need   of  the  time  that  pharmacist and  
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Table 1: Baseline characteristics of study groups  
  













Age (years)  
o Mean  
















Waist circumference  
o Mean  








o No formal education  
o 10th Grade 










Smokers (%) 22.9 27.5 
Type of diabetes (%) 
o Type 1 







Blood pressure (%) 








Insulin use (%) 
 
14.1 8.3 















































physician should work collaboratively in 
management of diabetic patients. 
 
In this study there was significant increase in 
medication adherence rates and disease related 
knowledge in the intervention group. Increase in 
disease- related knowledge can improve the 
medication adherence rates as seen in this 
study. Patients who were in direct contact with 
the pharmacist showed better preventive care 
attributes as required by the management 
guidelines [12]. The present study has 
demonstrated that increase in self-monitoring of 
blood glucose levels may improve glycemic 
control but this is not in agreement with the 
results of other studies [13]. It was found that 
knowledge of HbA1c is poor among diabetic 
patients. Improvement in understanding of 
HbA1c is directly related with improvement in 
glycemic control as reported in other studies [14]. 
The present study also found that  increase in 
knowledge regarding dietary restrictions and 
exercise resulted in improvement in glycemic 
control as reported in other interventions studies 
aimed at increasing exercise combined with 
dietary restrictions [15]. Smoking can increase 
risk of diabetes associated complications and 
mortality [16]. The finding of this study indicated 
that smoking cessation can be promoted in 
diabetes patients by the pharmacist’s 
intervention
.  
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Table 2:  Comparison of primary outcomes between the groups 
 
Control group (n= 170) Intervention group (n=178)  Parameter 
0 month 
 





(95% CI, P 
value) 
0 month 5 month Difference 
from 
baseline 







CI, P value) 
BMI 32.01±8.08 31.42±7.31 -0.59 
P=0.46 






37.98±5.17 37.01±4.52 -0.97 
P=0.08 







175.48±60.64 168.17±53.25 -7.31 
P=0.23 




HbA1c (%) 8.54±1.55 8.08±1.49 -0.46 
P=0.11 





apaired sample t-tests for comparing differences between groups at 0 and 20 weeks; bintervention effects by 
comparing means of both groups at the end of study 
 
Table 3:  Comparison of adherence, disease knowledge and self-care activities between the groups 
  
Control group (n= 170) Intervention group (n=178)  Parameter 
0 month 
 
5 month Difference 
from 
baseline 
(95% CI, P 
value) 





















































































This study was limited to diabetes patients to 
evaluate the outcomes of pharmacists’ 
intervention in drug therapy and patient 
education. Further, this study did not account for 
the microvascular and macrovascular 
complications associated with diabetes and the 
results of intervention on these complications. 
Patients who were solely on insulin therapy were 
not included in this study. This study was 
conducted in patients in only two major hospitals 
in southern Punjab, and hence it cannot be 
generalized to the whole diabetes population of 
Pakistan due to pharmacogenomic variations. 
Limited biasing may be inherent in the 
parameters measured on ‘yes/no’ basis but this 
effect was minimized by the large group size and 





This study further supports the evidence that 
pharmacists’ led intervention programs for 
diabetes patients can improve glycemic control, 
medication adherence and disease related 
knowledge.  It further shows that if physicians 
and pharmacists work collaboratively for clinical 
management of diabetes patients, better 
outcomes can be achieved. Therefore, it is 
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helpful to involve pharmacists in the activities of 
diabetes clinics as it is capabale of reducing 
diabetes-related morbidity and mortality. 
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